Quantum BioPharma Ltd. (QNTM) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Los analistas estiman Beneficio por acción (EPS) de $-3.18 y ingresos de $0.00B para el próximo año fiscal.
Historial de Beneficio por acción (EPS): 2024: real $-12.49 vs est $-3.18 (no alcanzó -292.6%). 2025: real $-8.11 vs est $-8.28 (superó +2.1%). Precisión del analista: 62%.
